Network-based inference framework for identifying cancer genes from gene expression data

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Yang, Bo ^a   Zhang, Junying ^a   Yin, Yaling ^a   Zhang, Yuanyuan ^a  

^a XIDIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E2; DECAY ACCELERATING FACTOR; MUCIN 1; PUMA PROTEIN; TSPYL5 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE REGULATORY NETWORK; GENETIC SUSCEPTIBILITY; ONCOGENE; PHENOTYPE; ALGORITHM; BREAST TUMOR; COMPUTER SIMULATION; FEMALE; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETIC DATABASE; GENETICS; HUMAN; MOLECULAR GENETICS; NEOPLASM; RECEIVER OPERATING CHARACTERISTIC; SIGNAL TRANSDUCTION; STANDARD; TUMOR GENE;

ALGORITHMS; BREAST NEOPLASMS; COMPUTER SIMULATION; DATABASES, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; GENE REGULATORY NETWORKS; GENES, NEOPLASM; HUMANS; MOLECULAR SEQUENCE ANNOTATION; NEOPLASMS; REFERENCE STANDARDS; ROC CURVE; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84884889100     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/401649     Document Type: Article

References (40)

1. Van De Vijver M. J., He Y. D., van 't Veer L. J., A gene-expression signature as a predictor of survival in breast cancer. New England Journal of Medicine 2002 347 25 1999 2009 10.1056/NEJMoa021967 (Pubitemid 35461656)
2. Sotiriou C., Neo S.-Y., McShane L. M., Korn E. L., Long P. M., Jazaeri A., Martiat P., Fox S. B., Harris A. L., Liu E. T., Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences of the United States of America 2003 100 18 10393 10398 2-s2.0-0042838307 10.1073/pnas.1732912100 (Pubitemid 37071889)
3. Alexe G., Alexe S., Axelrod D. E., Bonates T. O., Lozina I. I., Reiss M., Hammer P. L., Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Research 2006 8 4, article R41 2-s2.0-33748139952 10.1186/bcr1512 (Pubitemid 44314302)
4. Sotiriou C., Piccart M. J., Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nature Reviews Cancer 2007 7 7 545 553 2-s2.0-34250887474 10.1038/nrc2173 (Pubitemid 46985399)
5. Desmedt C., Piette F., Loi S., Wang Y., Lallemand F., Haibe-Kains B., Viale G., Delorenzi M., Zhang Y., D'Assignies M. S., Bergh J., Lidereau R., Ellis P., Harris A. L., Klijn J. G. M., Foekens J. A., Cardoso F., Piccart M. J., Buyse M., Sotiriou C., Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clinical Cancer Research 2007 13 11 3207 3214 2-s2.0-34250652449 10.1158/1078-0432.CCR-06-2765 (Pubitemid 46944903)
6. Subramanian A., Kuehn H., Gould J., Tamayo P., Mesirov J. P., GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics 2007 23 23 3251 3253 2-s2.0-36549027355 10.1093/bioinformatics/btm369 (Pubitemid 350187532)
7. Ashburner M., Ball C. A., Blake J.A., Gene ontology: tool for the unification of biology. Nature Genetics 2000 25 1 25 29 10.1038/75556 (Pubitemid 30257031)
8. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., Kanehisa M., KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research 1999 27 1 29 34 2-s2.0-0032919364 10.1093/nar/27.1.29 (Pubitemid 29209394)
9. Sotiriou C., Pusztai L., Gene-expression signatures in breast cancer. New England Journal of Medicine 2009 360 8 752 800 2-s2.0-60849097255 10.1056/NEJMra0801289
10. Wu K., House L., Liu W., Cho W. C. S., Personalized targeted therapy for lung cancer. International Journal of Molecular Sciences 2012 13 9 11471 11496
11. Chuang H.-Y., Lee E., Liu Y.-T., Lee D., Ideker T., Network-based classification of breast cancer metastasis. Molecular Systems Biology 2007 3 10.1038/msb4100180 (Pubitemid 47587026)
12. Wu X., Jiang R., Zhang M. Q., Li S., Network-based global inference of human disease genes. Molecular Systems Biology 2008 4, article 189 10.1038/msb.2008.27 (Pubitemid 351655223)
13. Fröhlich H., Network based consensus gene signatures for biomarker discovery in breast cancer. PloS ONE 2011 6 10 e25364 2-s2.0-84858791095
14. Chen L., Xuan J., Riggins R. B., Clarke R., Wang Y., Identifying cancer biomarkers by network-constrained support vector machines. BMC Systems Biology 2011 5, article 161 2-s2.0-80053918061 10.1186/1752-0509-5-161
15. Ideker T., Krogan N. J., Differential network biology. Molecular Systems Biology 2012 8, article 565 2-s2.0-84856094560 10.1038/msb.2011.99
16. Valcárcel B., Würtz P., Seich al Basatena N. K., A differential network approach to exploring differences between biological states: an application to prediabetes. PLoS ONE 2011 6 9 e24702
17. Gambardella G., Moretti M. N., de Cegli R., Differential network analysis for the identification of condition-specific pathway activity and regulation. Bioinformatics 2013 29 14 1776 1785 10.1093/bioinformatics/btt290
18. Iancu O. D., Oberbeck D., Darakjian P., Differential network analysis reveals genetic effects on catalepsy modules. PLoS ONE 2013 8 3 e58951 10.1371/journal.pone.0058951
19. West J., Bianconi G., Severini S., Teschendorff A. E., Differential network entropy reveals cancer system hallmarks. Scientific Reports 2012 2, article 802 10.1038/srep00802
20. Shen C. Y., Huang Y., Liu Y., A modulated empirical bayes model for identifying topological and temporal estrogen receptor alpha regulatory networks in breast cancer. BMC Systems Biology 2011 5, article 67 10.1186/1752-0509-5-67
21. Costantino C. L., Witkiewicz A. K., Kuwano Y., Cozzitorto J. A., Kennedy E. P., Dasgupta A., Keen J. C., Yeo C. J., Gorospe M., Brody J. R., The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Research 2009 69 11 4567 4572 2-s2.0-66349114705 10.1158/0008-5472.CAN-09-0371
22. Cotter T. G., Apoptosis and cancer: the genesis of a research field. Nature Reviews Cancer 2009 9 7 501 507 2-s2.0-67649595826 10.1038/nrc2663
23. Morrison J. L., Breitling R., Higham D. J., Gilbert D. R., GeneRank: using search engine technology for the analysis of microarray experiments. BMC Bioinformatics 2005 6, article 233 2-s2.0-27644503675 10.1186/1471-2105-6-233 (Pubitemid 41548722)
24. Smoot M. E., Ono K., Ruscheinski J., Wang P.-L., Ideker T., Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011 27 3 431 432 2-s2.0-79551587720 10.1093/bioinformatics/btq675
25. Skog J., Würdinger T., van Rijn S., Meijer D. H., Gainche L., Curry W. T., Carter B. S., Krichevsky A. M., Breakefield X. O., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology 2008 10 12 1470 1476 2-s2.0-57049103401 10.1038/ncb1800
26. Tibshirani R., Regression shrinkage and selection via the lasso: a retrospective. Journal of the Royal Statistical Society B 2011 73 3 273 282 2-s2.0-79955040218 10.1111/j.1467-9868.2011.00771.x
27. Geeven G., van Kesteren R. E., Smit A. B., de Gunst M. C. M., Identification of context-specific gene regulatory networks with GEMULA-gene expression modeling using LAsso. Bioinformatics 2012 28 2 214 221 2-s2.0-84856116180 10.1093/bioinformatics/btr641
28. Van den Bulcke T., Van Leemput K., Naudts B., van Remortel P., Ma H., Verschoren A., de Moor B., Marchal K., SynTReN: a generator of synthetic gene expression data for design and analysis of structure learning algorithms. BMC Bioinformatics 2006 7, article 43 2-s2.0-33144486498 10.1186/1471-2105-7-43 (Pubitemid 43264303)
29. Wang Y., Klijn J. G. M., Zhang Y., Sieuwerts A. M., Look M. P., Yang F., Talantov D., Timmermans M., Meijer-Van Gelder M. E., Yu J., Jatkoe T., Berns E. M. J. J., Atkins D., Foekens J. A., Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005 365 9460 671 679 2-s2.0-13844310310 10.1016/S0140-6736(05)17947-1 (Pubitemid 40260888)
30. Edgar R., Domrachev M., Lash A. E., Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 2002 30 1 207 210 2-s2.0-0036081355 (Pubitemid 34679544)
31. McEntyre J., Lipman D., PubMed: bridging the information gap. Canadian Medical Association Journal 2001 164 9 1317 1319 2-s2.0-0034916009 (Pubitemid 32702045)
32. Lv W., Yang T., Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clinical Biochemistry 2012 45 1-2 127 133 2-s2.0-84855333543 10.1016/j.clinbiochem.2011.10.011
33. Vogelstein B., Kinzler K. W., Cancer genes and the pathways they control. Nature Medicine 2004 10 8 789 799 2-s2.0-4043181214 10.1038/nm1087 (Pubitemid 39070849)
34. Dennis G. Jr., Sherman B. T., Hosack D. A., Yang J., Gao W., Lane H. C., Lempicki R. A., DAVID: database for annotation, visualization, and integrated discovery. Genome Biology 2003 4 5 P3 2-s2.0-0038005018
35. Henikoff S., Nucleosome destabilization in the epigenetic regulation of gene expression. Nature Reviews Genetics 2008 9 1 15 26 2-s2.0-37249012276 10.1038/nrg2206 (Pubitemid 350277297)
36. Sieuwerts A. M., Look M. P., Meijer-Van Gelder M. E., Timmermans M., Trapman A. M. A. C., Garcia R. R., Arnold M., Goedheer A. J. W., De Weerd V., Portengen H., Klijn J. G. M., Foekens J. A., Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. Clinical Cancer Research 2006 12 11 I 3319 3328 2-s2.0-33745185501 10.1158/1078-0432.CCR-06-0225
37. Madjd Z., Durrant L. G., Bradley R., Spendlove I., Ellis I. O., Pinder S. E., Loss of CD55 is associated with aggressive breast tumors. Clinical Cancer Research 2004 10 8 2797 2803 2-s2.0-1942470075 10.1158/1078-0432.CCR-1073-03 (Pubitemid 38509158)
38. Raj L., Ide T., Gurkar A. U., Selective killing of cancer cells by a small molecule targeting the stress response to ros. Nature 2011 475 7355 231 234 10.1038/nature10167
39. Ibrahim N. K., Yariz K. O., Bondarenko I., Manikhas A., Semiglazov V., Alyasova A., Komisarenko V., Shparyk Y., Murray J. L., Jones D., Senderovich S., Chau A., Erlandsson F., Acton G., Pegram M., Randomized phase II trial of letrozole plus Anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer. Clinical Cancer Research 2011 17 21 6822 6830 2-s2.0-80455144484 10.1158/1078-0432.CCR-11-1151
40. Kufe D. W., Muc1-c oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 2012